Bipolar Disorder — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for bipolar disorder. 1 active patents protecting 1 drugs from 0+ originators. First major cliff: 2026. Daily refresh.

1
Approved drugs
1
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators in Bipolar Disorder

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating bipolar disorder. Each bar = one year. Y-axis scaled to peak year (1 patents).

1
26

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Adasuve
LOXAPINE
 — 1 65 — 2026-10-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8387612 Adasuve formulation 65 2026-10-23

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8387612 Adasuve formulation 65 2026-10-23

Related